Integrated Shield Plans

<h1>Integrated Shield Plans</h1> <p>Integrated Shield Plans (IPs) are Singapore's optional private hospital-insurance policies that layer additional coverage on top of compulsory <a href="/en/knowledge/article/sgkb.healthcare.healthcare-financing">MediShield Life</a>, which every Singapore citizen and permanent resident already holds. An IP is <strong>not</strong> a substitute for MediShield Life: it is sold by a licensed private insurer as a single integrated policy whose MediShield Life component remains sized for subsidised Class B2/C care in public hospitals, while the insurer's add-on targets higher ward classes or private hospitals (<a href="https://www.moh.gov.sg/managing-expenses/schemes-and-subsidies/integrated-shield-plans/about-integrated-shield-plans/">MOH, accessed Aug 2026</a>). Roughly two-thirds of Singapore residents hold an IP — about 2.86 million policyholders as of 2021 (<a href="https://www.moh.gov.sg/others/resources-and-statistics/government-health-expenditure-and-healthcare-financing/">MOH statistics, accessed Aug 2026</a>) — making IPs central to how middle- and upper-income Singaporeans finance unsubsidised hospital care, even though MediShield Life alone remains adequate for subsidised public wards. Dated Additional Withdrawal Limits, minimum deductibles, and rider rules are tabulated in <a href="/en/knowledge/dataset/sgkb.data.integrated-shield-anchors">integrated shield anchors</a>; this article does not quote insurer-specific commercial premium schedules that change by age, tier, and underwriting.</p> <h2>How IPs extend MediShield Life</h2> <p>An Integrated Shield Plan has two legally distinct but administratively unified parts. The <strong>MediShield Life component</strong> is run by the CPF Board and cannot be opted out of; it covers large hospital bills and selected high-cost outpatient treatments, with benefits pegged to subsidised B2/C wards. The <strong>additional private insurance component</strong> is underwritten by the insurer and pays for care above that baseline — Class B1, A, or private-hospital treatment, direct specialist access without a subsidised referral, and typically higher annual claim limits (<a href="https://www.cpf.gov.sg/member/healthcare-financing/getting-supplementary-coverage/integrated-shield-plan">CPF Board, accessed Aug 2026</a>). The private insurer is the policyholder's single point of contact: it collects the combined premium, processes claims, and acts for the CPF Board on the MediShield Life portion (<a href="https://www.moh.gov.sg/managing-expenses/schemes-and-subsidies/integrated-shield-plans/about-integrated-shield-plans/">MOH, accessed Aug 2026</a>).</p> <p>MediShield Life within an IP continues for life and covers pre-existing conditions even when the insurer's add-on excludes them. A resident may hold only one IP at a time; switching insurers is permitted but underwriting rules apply to the new private component. MOH publishes side-by-side comparison tables of every licensed plan's benefits, deductibles, and common claim-rejection reasons — notably, about 69% of claims that pay nothing on the private component do so because the bill falls at or below the annual deductible (<a href="https://www.moh.gov.sg/managing-expenses/schemes-and-subsidies/integrated-shield-plans/comparision-of-integrated-shield-plans/">MOH comparison tables, accessed Aug 2026</a>). Hospital subsidy rules under MOH means testing are separate from IP entitlement; a patient in a subsidised C ward still receives ward subsidies, while an IP's payout depends on the purchased tier (see <a href="/en/knowledge/article/sgkb.healthcare.hospitals">hospitals</a>).</p> <h2>Coverage tiers and insurers</h2> <p>Seven private insurers are licensed to sell IPs: AIA, Great Eastern, HSBC Life, Income, Prudential, Raffles Health Insurance, and Singlife (<a href="https://www.moh.gov.sg/managing-expenses/schemes-and-subsidies/integrated-shield-plans/comparision-of-integrated-shield-plans/">MOH comparison tables, accessed Aug 2026</a>). Plans are grouped by the ward class they target, in ascending cost and breadth:</p> <table> <thead> <tr> <th>Tier</th> <th>Typical target</th> <th>Distinctive feature</th> </tr> </thead> <tbody> <tr> <td>Standard B1</td> <td>Class B1 in public hospitals</td> <td>Benefits are <strong>identical across all seven insurers</strong> by MOH mandate; only premiums differ</td> </tr> <tr> <td>Enhanced B1</td> <td>Class B1 with higher limits</td> <td>Insurers compete on annual limits and &quot;as-charged&quot; sub-limits</td> </tr> <tr> <td>Class A</td> <td>Class A in public hospitals</td> <td>Single-bedded rooms, choice of specialist; higher policy-year limits</td> </tr> <tr> <td>Private hospital</td> <td>Private hospitals</td> <td>Highest tier; most plans offer as-charged coverage with limits typically from about S$1 million upward</td> </tr> </tbody> </table> <p>Choosing a tier above what a patient actually uses triggers <strong>pro-ration</strong>: staying in a ward class higher than the plan's target leaves a larger share of the bill uninsured. A private-hospital IP used for a subsidised B2/C stay still pays, but less generously than for its intended setting (<a href="https://www.cpf.gov.sg/content/dam/web/member/healthcare/documents/Claim%20Illustrations%20and%20Benefits%20Premiums%20Comparisons.pdf">CPF Board claim illustrations, accessed Aug 2026</a>). Insurers maintain <strong>main panels</strong> of specialists offering pre-authorisation and lower co-payment; an industry <strong>Extended Panel</strong> framework extends some panel benefits to selected off-panel doctors (<a href="https://www.moh.gov.sg/managing-expenses/schemes-and-subsidies/integrated-shield-plans/about-integrated-shield-plans/">MOH, accessed Aug 2026</a>). As of 2023, 38% of citizens and permanent residents held the highest private-hospital tier, down from 40% in 2021, while uptake among those aged 60 and below continued to rise (<a href="https://www.straitstimes.com/singapore/fewer-people-on-private-hospital-ips-more-older-people-giving-up-their-plans-altogether">ST, Apr 2024</a>).</p> <h2>Premiums, deductibles, and co-payment</h2> <p>IP premiums rise steeply with age. The CPF Board notes that the private component alone can reach several times MediShield Life premiums for someone in their 70s or 80s (<a href="https://www.cpf.gov.sg/member/healthcare-financing/getting-supplementary-coverage/integrated-shield-plan">CPF Board, accessed Aug 2026</a>). MediShield Life premiums within the IP are fully payable from MediSave; the private component is MediSave-payable only up to <strong>Additional Withdrawal Limits</strong> by age next birthday — S$300 (ages 1–40), S$600 (41–70), and S$900 (71 and above) — with any excess in cash (<a href="/en/knowledge/dataset/sgkb.data.integrated-shield-anchors">integrated shield anchors</a>; <a href="https://www.cpf.gov.sg/service/article/what-are-additional-withdrawal-limits-awls-for-integrated-shield-plan-ip-premiums">CPF Board AWL guidance, accessed Aug 2026</a>). MOH regulates premium <strong>structure</strong> and cost-sharing parameters but not each insurer’s commercial price list; insurers reprice annually and must give 30 days' notice (<a href="https://www.moh.gov.sg/newsroom/measures-to-manage-increases-to-base-integrated-shield-plan-premiums/">MOH, accessed Aug 2026</a>). Between December 2021 and December 2024, private-hospital base IP premiums rose at an average compound rate of 8.6% per year and private-hospital rider premiums at 17.2% — industry aggregates, not a resident’s renewal quotation (<a href="https://www.moh.gov.sg/newsroom/measures-to-manage-increases-to-base-integrated-shield-plan-premiums/">MOH, accessed Aug 2026</a>).</p> <p>Every IP must carry MOH-set <strong>minimum deductibles</strong> per policy year (payable once, accumulable across bills): S$1,500 for Class C, S$2,000 for B2, S$2,500 for B1, and S$3,500 for Class A or private hospitals, with the applicable amount being the lower of the plan's target tier and the ward actually used (<a href="https://www.moh.gov.sg/newsroom/new-requirements-for-integrated-shield-plan-riders-to-strengthen-sustainability-of-private-health-insurance-and-address-rising-healthcare-costs/">MOH Nov 2025 rider announcement, accessed Aug 2026</a>). After the deductible, the patient pays <strong>10% co-insurance</strong> on the remainder (capped annually per MOH tables), preserving co-payment even within insurance. Deductibles and co-insurance can be paid from MediSave subject to withdrawal limits. MOH's general practice is not to intervene in premium levels, but it does set these cost-sharing parameters so IPs remain sustainable alongside subsidised care.</p> <h2>Critical perspectives: riders and sustainability reforms</h2> <p><strong>Riders</strong> are optional cash-paid add-ons that further reduce out-of-pocket costs on top of the main IP. Before 2018, &quot;full&quot; riders could cover the entire deductible and co-insurance — first-dollar coverage that MOH linked to over-servicing, over-charging, and rapidly rising claims: between 2015 and 2020, full-rider claim incidence grew at about 15% compound annual rate for private-hospital IPs, with average bill sizes at least 20% above riders that retained some co-payment (<a href="https://www.moh.gov.sg/newsroom/co-payment-in-integrated-shield-plans-for-specific-hospital-categories-and-breakdown-of-average-claims-made-through-full-riders-of-integrated-shield-plans/">MOH, accessed Aug 2026</a>).</p> <p>From <strong>1 April 2019</strong>, all new riders must include at least <strong>5% co-payment</strong>, with insurers typically capping annual co-payment at S$3,000 for panel or pre-authorised treatment (higher caps are permitted; non-panel care has no cap). Legacy full riders bought before March 2018 were grandfathered initially, but insurers have since migrated many holders onto co-payment designs. In <strong>November 2025</strong>, MOH announced a second tightening effective <strong>1 April 2026</strong>: new riders may no longer cover MOH minimum deductibles, and the minimum annual co-payment cap rises from S$3,000 to <strong>S$6,000</strong> (excluding the deductible). MOH expects new compliant riders to cost about 30% less on average than maximum-coverage legacy riders, with all seven insurers launching compliant products by April 2026 (<a href="https://www.moh.gov.sg/newsroom/new-requirements-for-integrated-shield-plan-riders-to-strengthen-sustainability-of-private-health-insurance-and-address-rising-healthcare-costs/">MOH, accessed Aug 2026</a>). Policyholders who bought non-compliant riders on or after 27 November 2025 must transition at their next renewal after 1 April 2028. Rider premiums must be paid entirely in cash — they are not MediSave-deductible.</p> <p>The policy arc reflects MOH's view that insurance should protect against catastrophic bills, not eliminate all co-payment on routine episodes. Private-hospital IP holders with riders were 1.4 times as likely to claim and at 1.4 times the average claim size of those without riders, feeding a &quot;knot&quot; of rising bills and premiums that MOH is also addressing through fee benchmarks, claims enforcement, and exploration of a not-for-profit private hospital (<a href="https://www.moh.gov.sg/newsroom/new-requirements-for-integrated-shield-plan-riders-to-strengthen-sustainability-of-private-health-insurance-and-address-rising-healthcare-costs/">MOH, accessed Aug 2026</a>).</p> <h2>Choosing and maintaining coverage</h2> <p>A resident who is comfortable with subsidised B2/C wards in public hospitals and does not need to choose a specialist without referral may find MediShield Life sufficient; the CPF Board explicitly frames that as the default for cost-conscious households (<a href="https://www.cpf.gov.sg/member/healthcare-financing/getting-supplementary-coverage/integrated-shield-plan">CPF Board, accessed Aug 2026</a>). An IP becomes relevant for Class A or B1 preference, private-hospital access, or unrestricted specialist choice. The decision turns on long-term affordability: premiums escalate with age, cash top-ups above AWLs grow, and downgrading or lapsing later may face underwriting exclusions on the private component.</p> <p>Coverage status can be checked on the CPF Healthcare dashboard via Singpass. Disputes with insurers go to the Financial Industry Disputes Resolution Centre under MAS insurance regulations. Between 2020 and 2023, 2.2% of residents aged over 60 surrendered their IPs entirely, reverting to MediShield Life alone, even as younger cohorts continued to buy in (<a href="https://www.straitstimes.com/singapore/fewer-people-on-private-hospital-ips-more-older-people-giving-up-their-plans-altogether">ST, Apr 2024</a>). The wider financing context — subsidies, MediSave, MediFund, and CareShield Life for long-term disability — is covered in <a href="/en/knowledge/article/sgkb.healthcare.healthcare-financing">healthcare financing</a>; ward-class and referral mechanics that determine subsidy and insurance interaction are in <a href="/en/knowledge/article/sgkb.healthcare.hospitals">hospitals</a> and <a href="/en/knowledge/article/sgkb.healthcare.polyclinics-and-primary-care">polyclinics and primary care</a>.</p>

简介

综合医疗保险计划

综合医疗保险计划( IP )是新加坡可选的私人住院保险,在强制性的 MediShield Life 基础上增加保障。每位新加坡公民和永久居民都已持有 MediShield Life。 IP 不能取代 MediShield Life:它由持牌私人保险公司作为一份综合保单销售,其中 MediShield Life 部分仍按公立医院补贴病房 B2/C 级设计,而保险公司的附加部分面向更高级别病房或私立医院(MOH,访问于 2026 年 八月)。约三分之二的新加坡居民持有 IP,截至 2021 年约有 2.86 million 名保单持有人(MOH 统计,访问于 2026 年 八月)。因此,IP 是中高收入新加坡人支付非补贴住院护理费用的重要方式,不过 MediShield Life 单独也足以应付补贴公立病房。 综合保险计划参数表列出有日期的额外提款限额、最低自付额及附加险规则;本文不引用会随年龄、等级和核保而变动的保险公司商业保费表。

IP 如何扩展 MediShield Life

综合医疗保险计划包含两个法律上不同、行政上统一的部分。MediShield Life 部分由 CPF Board 管理,不能退出;它承保大额住院账单和部分高费用门诊治疗,福利以补贴 B2/C 级病房为基准。私人附加保险部分由保险公司承保,支付超出该基准的护理费用,例如 B1、A 级或私立医院治疗、无需补贴转诊即可直接看专科,以及通常更高的年度理赔限额(CPF Board,访问于 2026 年 八月)。私人保险公司是保单持有人的单一联络点:收取合并保费、处理理赔,并代表 CPF Board 处理 MediShield Life 部分(MOH,访问于 2026 年 八月)。

IP 中的 MediShield Life 终身有效,即使保险公司的附加部分排除既有疾病,仍会承保既有疾病。居民同一时间只能持有一份 IP;可以更换保险公司,但新的私人部分须遵守核保规则。 MOH 发布所有持牌计划的福利、自付额和常见拒赔原因对照表。私人部分没有赔付的理赔中,约 69% 是因为账单不超过年度自付额(MOH 对照表,访问于 2026 年 八月)。MOH 经济状况审查下的医院补贴规则与 IP 资格分开:患者入住补贴 C 级病房仍可获得病房补贴,而 IP 的赔付取决于购买的等级(参见医院)。

保障等级与保险公司

七家私人保险公司获准销售 IP:AIA、Great Eastern、HSBC Life、Income、Prudential、Raffles Health Insurance 和 Singlife(MOH 对照表,访问于 2026 年 八月)。计划按目标病房等级分类,费用和保障范围依次增加:

等级 典型目标 特点
标准 B1 公立医院 B1 级病房 根据 MOH 要求,七家保险公司的福利 完全相同;仅保费不同
增强 B1 B1 级病房,限额较高 保险公司在年度限额和“按实际收费”子限额方面竞争
A 级 公立医院 A 级病房 单人房、可选择专科医生;保单年度限额较高
私立医院 私立医院 最高等级;多数计划提供按实际收费保障,限额通常约从 S$1 million 起

若选择高于患者实际使用等级的计划,会触发按比例赔付:入住高于计划目标等级的病房,意味着账单中较大部分不受保险保障。用于补贴 B2/C 级住院的私立医院 IP 仍会赔付,但不如在其预定适用场景下慷慨(CPF Board 理赔示例,访问于 2026 年 八月)。保险公司设有提供预先授权和较低共同支付的主要医生网络;行业的扩展网络机制则把部分网络福利延伸至特定网络外医生(MOH,访问于 2026 年 八月)。截至 2023 年,38% 的公民和永久居民持有最高级别的私立医院计划,低于 2021 年的 40%;60 岁及以下人群的投保率则继续上升(ST,2024 年 四月)。

保费、自付额与共同支付

IP 保费随年龄大幅上涨。CPF Board 指出,七十或八十多岁人士的私人部分保费可能达到 MediShield Life 保费的数倍(CPF Board,访问于 2026 年 八月)。IP 中的 MediShield Life 保费可全额由 MediSave 支付;私人部分只能在按下一次生日年龄确定的额外提款限额内使用 MediSave 支付:S$300(1–40 岁)、S$600(41–70 岁)和 S$900(71 岁及以上),超额部分须现金支付(综合保险计划参数表;CPF Board 额外提款限额指南,访问于 2026 年 八月)。MOH 监管保费结构和费用分担参数,但不规定每家保险公司的商业价目表;保险公司每年重新定价,并须提前 30 天通知(MOH,访问于 2026 年 八月)。2021 年 十二月至 2024 年 十二月期间,私立医院基础 IP 保费年均复合增幅为 8.6%,私立医院附加险保费为 17.2%;这些是行业汇总数据,不代表某位居民的续保报价(MOH,访问于 2026 年 八月)。

每份 IP 均须遵守 MOH 设定的最低自付额(每个保单年度支付一次,可由多张账单累计):C 级 S$1,500、B2 级 S$2,000、B1 级 S$2,500、A 级或私立医院 S$3,500;适用金额取计划目标等级与实际使用病房等级两者中较低者(MOH 2025 年 十一月附加险公告,访问于 2026 年 八月)。达到自付额后,患者须对余额支付 10% 共同保险(按 MOH 表格设有年度上限),因此即使有保险仍须共同承担费用。自付额和共同保险可在提款限额内使用 MediSave 支付。MOH 通常不干预保费水平,但会设定这些费用分担参数,使 IP 与补贴医疗服务并行时仍可持续。

重要考量:附加险与可持续性改革

附加险是可选的现金付费附加保障,可进一步减少主 IP 以外的自付费用。2018 年以前,“全额”附加险可承担全部自付额和共同保险,即首元全额保障。MOH 认为这会导致过度服务、过度收费和理赔迅速增长:2015 年至 2020 年,私立医院 IP 全额附加险的理赔率年复合增长约 15%,平均账单至少比保留部分共同支付的附加险高 20%(MOH,访问于 2026 年 八月)。

自 2019 年 四月 1 日起,所有新附加险必须包含至少 5% 共同支付;对于网络内或预先授权治疗,保险公司通常把年度共同支付上限设为 S$3,000(允许更高上限;网络外护理没有上限)。2018 年 三月前购买的旧全额附加险最初获准保留,但保险公司此后已将许多持有人转至共同支付方案。2025 年 十一月,MOH 宣布第二轮收紧措施,于 2026 年 四月 1 日生效:新附加险不得再承保 MOH 最低自付额,最低年度共同支付上限从 S$3,000 提高至 S$6,000(不包括自付额)。MOH 预计,合规新附加险平均比最高保障的旧附加险便宜约 30%,七家保险公司均将在 2026 年 四月前推出合规产品(MOH,访问于 2026 年 八月)。2025 年 十一月 27 日或之后购买不合规附加险的保单持有人,须在 2028 年 四月 1 日之后的下一次续保时转换。附加险保费必须全额以现金支付,不能从 MediSave 扣除。

这项政策演变反映 MOH 的观点:保险应防范灾难性账单,而非消除日常医疗事件中的所有共同支付。持有附加险的私立医院 IP 投保人提出理赔的可能性是未持附加险者的 1.4 倍,平均理赔金额也是 1.4 倍,形成账单和保费上涨的“结”,MOH 也正通过费用基准、理赔执法和探索非营利私立医院来应对(MOH,访问于 2026 年 八月)。

选择和维持保障

若居民接受公立医院补贴 B2/C 级病房,且不需要无需转诊即可选择专科医生,MediShield Life 可能已足够;CPF Board 明确将其作为注重成本家庭的默认选择(CPF Board,访问于 2026 年 八月)。若偏好 A 或 B1 级病房、需要私立医院服务或不受限制地选择专科医生,则可考虑 IP。决策取决于长期负担能力:保费随年龄上升,超过额外提款限额的现金补缴增加,日后降级或保单失效时,私人部分可能受到核保除外条款影响。

可通过 Singpass 登录 CPF Healthcare 仪表板查询保障状态。与保险公司的争议可提交金融业争议调解中心,并适用 MAS 保险法规。2020 年至 2023 年,60 岁以上居民中有 2.2% 完全放弃 IP,转而只保留 MediShield Life,尽管较年轻群体仍持续投保(ST,2024 年 四月)。更广泛的融资背景,包括补贴、MediSave、MediFund,以及针对长期残障的 CareShield Life,见医疗保健融资;决定补贴与保险如何互动的病房等级和转诊机制,见医院及综合诊疗所与基层医疗。